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Human herpesviruses 6A and 6B (HHV-6A and HHV-6B)
are lymphotropic herpes viruses that play a role in the
pathogenesis of roseola and febrile illness. HHV-6 is con-
sidered a common, ubiquitous virus of humans with a
seroprevalence of greater than 90% in the general popula-
tion. The HHV6 variants have been shown to be distinct
and have different cell tropisms, disease associations and
reactivity to monoclonal antibodies. While HHV-6B is
spread through saliva, the mode of transmission of HHV-
6A is not known. HHV-6 predominantly infects CD4 cells,
adversely affecting function. HHV-6A, but not HHV-6B
also invades CD8 cells. HHV-6 is increasingly being recog-
nized as an emerging pathogen with recently reported
associations of both CNS and systemic disease. These
include disorders associated with seizures and encephali-
tis, transplant morbidity, multiple sclerosis, epilepsy, can-
cer, drug induced hypersensitivity syndrome, and
immunosuppression. As HHV-6 has been linked to a
number of chronic, human disorders further studies are
required to elucidate the causal relationship of this virus
to the pathogenesis of such diseases. Since our first detec-
tion of HHV-6 DNA in diseased brain tissue from a subset
of epilepsy patients, an extended cohort of patients with
or without mesial temporal sclerosis has been progres-
sively studied, confirming our preliminary results on an
association of HHV-6 CNS infection and mesial temporal
lobe epilepsy. To validate the extent and distribution of
HHV-6 in glial cells, brain tissue from surgical resections
was processed to establish cultures of primary astrocytes.
The detection of viral late gene transcripts confirmed the
presence of active infection in these cultured cells. Viral
DNA was documented in cultured astrocytes by quantita-
tive TaqMan and nested PCR. This is the first demonstra-
tion of an HHV-6 infection detected in vivo and
maintained in primary cultured astrocytes. These results
confirm our previous findings on epilepsy brain resec-
tions and support an association of HHV-6 active infec-
tion in this disorder. These data open a new perspective
into the study of pathogenesis of mesial temporal lobe
epilepsy.
from 2006 International Meeting of The Institute of Human Virology
Baltimore, USA. 17–21 November, 2006
Published: 21 December 2006
Retrovirology 2006, 3(Suppl 1):S64 doi:10.1186/1742-4690-3-S1-S64
<supplement> <title> <p>2006 International Meeting of The Institute of Human Virology</p> </title> <note>Meeting abstracts. A single PDF containing all abstracts in this Supplement is available <a href=" http://www.biomedcentral.com/content/files/pdf/1742-4690-3-S1-full.pdf ">here</a></note> <url>http://www.biomedcentral.com/content/pdf/1742-4690-3-S1-info.pdf</url></supplement>
© 2006 Jacobson; licensee BioMed Central Ltd. 